DocGo Inc.
(DCGO)
undefined
undefined%
At close: undefined
4.29
0.35%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom.
The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts.
DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
DocGo Inc.
Country | United States |
IPO Date | Dec 17, 2020 |
Industry | Medical - Care Facilities |
Sector | Healthcare |
Employees | 2,915 |
CEO | Lee Bienstock |
Contact Details
Address: 35 West 35th Street New York, New York United States | |
Website | https://www.docgo.com |
Stock Details
Ticker Symbol | DCGO |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001822359 |
CUSIP Number | 256086109 |
ISIN Number | US2560861096 |
Employer ID | 85-2515483 |
SIC Code | 8000 |
Key Executives
Name | Position |
---|---|
Dr. James Powell M.D. | Chief Executive Officer of Clinical Practice Group & Member of Medical Advisory Board |
Lee Bienstock | Chief Executive Officer & Director |
Eiwe Lingefors | Chief Information Officer |
Norman Rosenberg | Treasurer & Chief Financial Officer |
Andre Oberholzer CPA | Executive Vice President of Strategy |
Ely D. Tendler J.D. | General Counsel, Secretary & Director |
Mike Cole | Vice President of Investor Relations |
Rosemarie Milano | Vice President of Human Resources |
Stephen Sugrue | Chief Compliance Officer |
Vrenely Munoz | Chief Revenue Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 29, 2024 | SC 13D/A | [Amend] Filing |
Nov 14, 2024 | 4 | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 07, 2024 | 10-Q | Quarterly Report |
Nov 07, 2024 | 8-K | Current Report |
Oct 04, 2024 | 4 | Filing |
Oct 04, 2024 | 4 | Filing |
Oct 04, 2024 | 4 | Filing |
Oct 01, 2024 | 3 | Filing |
Sep 30, 2024 | 8-K | Current Report |